Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/49770
Conference/Presentation Title: | Dysfunctional breathing induces vocal cord dysfunction following COVID-19 infection. | Authors: | Laurence R.;Joo K.;Malcolm B.;Paul L.;Garun H.;Paul F.;Philip B. | Institution: | (Laurence, Joo, Malcolm, Paul, Garun, Paul, Philip) Monash Health, Clayton, Australia (Laurence, Joo, Paul, Garun, Philip) Monash University, Clayton, Australia |
Presentation/Conference Date: | 3-May-2023 | Copyright year: | 2023 | Publisher: | John Wiley and Sons Inc | Publication information: | Respirology. Conference: TSANZSRS 2023 Australia and New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health and Respiratory Science. Christchurch New Zealand. 28(Supplement 2) (pp 21), 2023. Date of Publication: March 2023. | Journal: | Respirology | Abstract: | Introduction/Aim: SARS-CoV-2 (COVID-19) has affected over 60 million people world-wide. In most cases symptoms are mild, however some people have ongoing symptoms lasting longer known as 'long COVID'. Exertional breathlessness is a common complaint in these patients. Dysfunctional breathing (DB) and vocal cord dysfunction (VCD) are two underappreciated causes of breathlessness. We hypothesized that in individuals who had experienced COVID-19, dysfunctional breathing could give rise to VCD. Method(s): Nine convenience-sampled participants with confirmed COVID-19 infection were included following resolution of the acute illness. Vocal cords movements were visualised via continuous laryngoscopy. Hyperventilation was employed as a surrogate for DB, using a standard protocol of 40 breathes per minute (bpm). Participants breathed through a flow sensor with concomitant laryngoscopy, and we monitored hyperventilation, gas exchange measurements and laryngeal movements. After 12-weeks patients returned for repeat hyperventilation testing. Result(s): The nine participants consisted of five females and four males, age range 24-66 years. Three of the nine participants developed classic inspiratory VCD during hyperventilation. Patients with VCD were female, younger (<45), reported significantly reduced exercise tolerance post infection and had been physically very active prior to COVID infection. In two participants VCD associated with hyperventilation had resolved on laryngoscopy at 12-weeks. In these two participants who had VCD, breathlessness and reduced exercise tolerance resolved at 12-weeks following laryngeal retraining. In one person evidence of VCD and reduced exercise tolerance persisted post 12-weeks review. Conclusion(s): This study provides the first evidence that COVID-19 may facilitate VCD via DB, causing unexplained breathlessness. Our findings suggest that this disease process may be implicated in 'long COVID' and provide a rationale for therapies such as breathing and laryngeal retraining. | Conference Name: | TSANZSRS 2023 Australia and New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health and Respiratory Science | Conference Start Date: | 2023-03-25 | Conference End Date: | 2023-03-28 | Conference Location: | Christchurch, New Zealand | DOI: | http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1111/resp.14458 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/49770 | Type: | Conference Abstract | Subjects: | breathing coronavirus disease 2019 dyspnea gas exchange hyperventilation laryngoscopy long COVID vocal cord vocal cord disorder |
Type of Clinical Study or Trial: | Observational study (cohort, case-control, cross sectional, or survey) |
Appears in Collections: | Conferences |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.